@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XR6MT7ZV-V skos:prefLabel "Cardiotoniques"@fr, "Cardiotonic Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-JW1542K8-8 mesh:allowableQualifier jvr:-FWD2BGQ0-9, jvr:-HQRFT0C6-B, jvr:-BT300B3G-Q, jvr:-XV06LPML-W, jvr:-Q3979798-W, jvr:-NHL3D2X0-S, jvr:-CB30NGKB-3, jvr:-R3QWLHRG-V, jvr:-TJHVZCRZ-0, jvr:-T9HQD7ST-J, jvr:-H7K65Q8S-Z, jvr:-R0ZCQ8X6-J, jvr:-THHNVC7V-3, jvr:-SBNWSM1T-R, jvr:-NB0XHT3S-N, jvr:-G4R176S9-J, jvr:-NFTHND7Q-8, jvr:-D0F21513-5, jvr:-W6SQV79N-S, jvr:-L6C0XPHT-4, jvr:-G30ZJ446-J, jvr:-WK5F724J-1, jvr:-S0CS1X5R-5, jvr:-NKM836P1-M, jvr:-M63HSDM7-1 ; skos:broader jvr:-FH8C43MZ-4, jvr:-R7M4BZ3H-T ; skos:hiddenLabel "Posiject"@en, "Dobutamina Rovi"@en, "Lactobionate de dobutamine"@fr, "Dobucor"@en, "Dobutamine Lactobionate"@en, "Dobutamine Hydrobromide"@en, "Dobutamine (+)-Isomer"@en, "Dobutamin Solvay"@en, "Dobuject"@en, "Dobutamine, Phosphate (1:1) Salt (+)-Isomer"@en, "Dobutamin Hexal"@en, "Dobutamin Fresenius"@en, "Dobutamin-ratiopharm"@en, "Tartrate de dobutamine"@fr, "Dobutrex"@en, "Chlorhydrate de dobutamine"@fr, "Dobutamine Tartrate"@en, "Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer"@en, "Dobutamine, (-)-Isomer"@en, "Dobutamine Hydrochloride"@en, "Lilly 81929"@en, "Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer"@en, "Bromhydrate de dobutamine"@fr, "Oxiken"@en, "Dobutamine Phosphate (1:1) Salt, (-)-Isomer"@en, "Dobutamina Inibsa"@en ; skos:altLabel "49745-95-1 (Dobutamine Hydrochloride)"@fr, "49745-95-1 (Dobutamine Hydrochloride)"@en, "104564-74-1"@fr, "104564-74-1"@en, "61661-06-1"@fr, "61661-06-1"@en, "34368-04-2 (Dobutamine)"@fr, "34368-04-2 (Dobutamine)"@en, "120885-54-3"@fr, "120885-54-3"@en, "101626-66-8 (Dobutamine Tartrate)"@fr, "101626-66-8 (Dobutamine Tartrate)"@en, "CP0YC140T9"@fr, "CP0YC140T9"@en, "5D1IB9AI6J"@fr, "5D1IB9AI6J"@en, "104564-71-8 (Dobutamine Lactobionate)"@fr, "104564-71-8 (Dobutamine Lactobionate)"@en, "3S12J47372"@fr, "3S12J47372"@en, "1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-"@fr, "1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)-"@en, "74753-15-4"@fr, "74753-15-4"@en, "0WR771DJXV"@fr, "0WR771DJXV"@en, "61661-05-0"@fr, "61661-05-0"@en, "120885-53-2"@fr, "120885-53-2"@en ; owl:sameAs ; skos:definition "A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY."@en ; skos:inScheme jvr: ; dc:modified "2018-06-30"^^xsd:date ; a skos:Concept, mesh:Descriptor ; mesh:pharmacologicalAction jvr:-PF128B09-N, jvr:-L4F8WZL2-8, jvr:-XR6MT7ZV-V ; dc:created "1975-07-18"^^xsd:date ; dc:established "1986-01-01"^^xsd:date ; skos:prefLabel "Dobutamine"@en, "Dobutamine"@fr . jvr:-R7M4BZ3H-T skos:prefLabel "Catécholamines"@fr, "Catecholamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-JW1542K8-8 . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-FH8C43MZ-4 skos:prefLabel "Phénéthylamines"@fr, "Phenethylamines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-JW1542K8-8 . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L4F8WZL2-8 skos:prefLabel "Adrenergic beta-1 Receptor Agonists"@en, "Agonistes des récepteurs bêta-1 adrénergiques"@fr ; a mesh:Descriptor, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-PF128B09-N skos:prefLabel "Sympathomimétiques"@fr, "Sympathomimetics"@en ; a mesh:Descriptor, skos:Concept .